Loading company financials…
NEW YORK STOCK EXCHANGE, INC. · Life Sciences Tools & Services · CIK 0001037646
$1677.94
+2.69% · delayed ~15 min
Last price from Oct 21, 2026
$34.16B market value
From METTLER TOLEDO INTERNATIONAL INC/'s FY2025 10-K, filed Feb 6, 2026 · read the filing
METTLER TOLEDO INTERNATIONAL / makes measuring and control instruments. It took in $4.03B last year, which makes it a mid-sized company. Of every dollar it sells, about 22 cents is left as profit.
The financial picture is led by profitability and debt, with growth worth watching.
A conclusion from the filings, not a recommendation. Detailed figures and supporting evidence appear in their dedicated sections below.
Recent open-market selling by 5 insiders, not under a pre-arranged plan.
$6.1M sold in the last 120 days · Read the filing
These are things the company filed or that a published model flagged — not predictions, and not a reason on their own to buy or sell anything.
Financial health
Strong finances across the board.
From METTLER TOLEDO INTERNATIONAL INC/'s FY2025 annual filing · share price scored separately
Largest year-over-year changes in FY2025
Long-term debt
$1.83B → $2.09B
Cash
$59.4M → $66.9M
Shares in issue
20.9M → 20.4M
3 of 4 scored areas had enough reported figures to judge
Measured against FY2024, from the 10-K filed Feb 6, 2026
Deteriorated: +14.0%
$1.83B to $2.09BNotable
Why it matters: Rising debt is not automatically bad — borrowing to build something that earns more than the interest is ordinary. It matters when it grows faster than the profit meant to service it.
Improved: +12.7%
$59.4M to $66.9MNotable
Why it matters: A falling cash pile is only a warning if the company is consuming it. Paying down debt, buying back stock and paying a dividend all reduce cash by choice.
How the latest move compares (quote delayed ~15 min), and what was published around it
MTD rose 2.69% on the latest quote. The average Technology company tracked here moved −1.29%, and the S&P 500 −1.04%. That is 4.0 points above its sector and 3.7 points above the market.
These coincide with the move in time. None is presented as its cause: a price can move on news that names no company, on the wider market, or on trading that no document records.
Expectations
Not from the filings — what other people are betting on, and what the price already assumes.
The growth rate someone buying today is paying for, against what the company has delivered
At today's price, the market is paying for free cash flow to grow by about 16% a year for the next 10 years. Over the last 10 years it grew by about 9% a year.
The essentials
Each answered from the filings, with the numbers behind it.
Yes. It keeps about 22 cents of every dollar of sales as profit, earning $869.2M last year.
Slowly. Sales grew 4.0% last year.
No. At its current cash flow it could clear its debt in about 2.2 years. For every $1 it owes, it owns $0.99 in assets.
Core operating and valuation reference metrics
Income
This company pays no dividend. It keeps its profits and reinvests them in the business instead, so any return would have to come from the share price.
Figures from the FY2025 annual filing
Last year it earned $869.2M and generated $955.8M of cash from operations.
Reported annual figures
As reported to the SEC, in USD. Hover or show sources to see where each figure came from.
| Income statement | FY202510-K · Feb 6, 2026Filing for FY2025 | FY202410-K · Feb 7, 2025Filing for FY2024 | FY202310-K · Feb 9, 2024Filing for FY2023 | FY202210-K · Feb 10, 2023Filing for FY2022 | FY202110-K · Feb 11, 2022Filing for FY2021 | ChangeFY2025 vs FY2024 |
|---|---|---|---|---|---|---|
| RevenueWhat is this? | $4.03B | $3.87B | $3.79B | $3.92B | $3.72B | +4.0% |
| Gross profit | $2.39B | $2.33B | $2.24B | $2.31B | $2.17B | +2.8% |
| Gross marginGross profit ÷ revenueWhat is this? | 59.4% | 60.1% | 59.2% | 58.9% | 58.4% | −0.7 pts |
| Selling, general and administrative | $998.3M | $936.3M | $904.1M | $938.5M | $944.0M | +6.6% |
| Interest expense | $68.5M | $74.6M | $77.4M | $55.4M | $43.2M | −8.2% |
| Income before tax | $1.05B | $1.04B | $973.7M | $1.07B | $949.4M | +1.1% |
| Net income | $869.2M | $863.1M | $788.8M | $872.5M | $769.0M | +0.7% |
| Net marginNet income ÷ revenueWhat is this? | 21.6% | 22.3% | 20.8% | 22.3% | 20.7% | −0.7 pts |
| Earnings per shareNet income ÷ shares outstanding at the period end — close to, but not the same as, the reported EPSWhat is this? | $42.69 | $41.20 | $36.64 | $39.41 | $33.66 | +3.6% |
† calculated from other reported figures, such as total liabilities as assets minus equity.
This company's latest filing beside its peers' stored scores
| Company | Health | F-Score | Revenue growth | Profit margin | P/E | Debt to equity |
|---|---|---|---|---|---|---|
| MTDMETTLER TOLEDO INTERNATIONAL INC/ · this page | 8.7/10 |
Insider activity, ownership stakes and what's coming — straight from EDGAR, before any article is written about it
Officers, directors and major shareholders must report within two business days of a trade.
Was granted or awarded shares — 16 shares
Holds 16 shares after this filing.
Exercised stock options — 942 shares at $1.0K ($965.1K)
Holds 5,422 shares after this filing.
20 recent filings, newest first. Each is labelled from its form and item numbers, not from its wording.
Had a director or senior officer leave or join · Made a Regulation FD disclosure
Read the filingQuarterly report for Q2 FY2024
Profit margin +2.1 pts · Profit +15.1% · Gross margin +4.3 pts — against Q2 FY2024
Read the filingWrite down why you are following METTLER TOLEDO INTERNATIONAL INC/, what has to go right and what would change your mind, then see each new annual report measured against it. Sign in to start one.
Go deeper
Every figure above traces back to a filing in the timeline, each linked to the document itself.
The 42 subsidiaries named in its 10-K, incorporated across 41 places. A filer lists the significant ones and may leave the rest out, so this is the floor rather than the full count.
Every company's figures are checked for internal consistency: the balance sheet adding up, figures sharing one currency, cash flow and share counts within plausible ranges, and how recent the latest annual report is. Nothing here changes a figure.
Financial figures are from MTD's 10-K for fiscal year 2025 (period ending 2025-12-31, filed Feb 6, 2026), reported under the US GAAP taxonomy. View the source filing.
The score averages profitability, growth, debt and accounting. Accounting had too few reported figures and is left out of the average rather than counted as a weakness, so a company is never marked down for a figure it did not publish. Cash generation is shown for context and already feeds profitability. Valuation is scored separately, because a share price says nothing about whether the business is sound. 9 of the 9 Piotroski checks could be evaluated. How the score works
Each year scored only from its annual report as it was first filed
| Fiscal year | Health | F-Score | Scored from |
|---|---|---|---|
| FY2025 | 8.7 | 7/9 | 10-K, filed Feb 6, 2026 |
| FY2024 | 8.7 | 7/9 | 10-K, filed Feb 7, 2025 |
| FY2023 | 7.3 | 6/9 | 10-K, filed Feb 9, 2024 |
| FY2022 | 8.7 | 7/9 | 10-K, filed Feb 10, 2023 |
| FY2021 | 10.0 | 7/9 | 10-K, filed Feb 11, 2022 |
| FY2020 | 8.7 | 7/9 | 10-K, filed Feb 8, 2021 |
A later restatement never reaches back into an earlier year, and every year is scored without a share price, so the latest point can differ a little from the headline score, which uses today's price.
Every check behind the three models, and what each one tests
7 of 9 checks passed
Nine yes-or-no tests of whether this year's finances improved on last year's.
11.10
In the safe zone
For this model, above 2.99 is safe and below 1.81 is distress.
Distance from bankruptcy, from a model fitted on companies that did and did not go bust. It describes a balance sheet's shape today; it does not forecast a failure.
not reported — This company has not reported enough of the required figures to calculate this score.
This company has not reported enough of the required figures to calculate this score.
Screens eight accounting ratios for the pattern earnings manipulators tend to leave. A flag is a reason to read the filing closely, never evidence of wrongdoing.
Every figure above comes from the FY2025 filing as filed with the SEC.
Improved: -2.8%
20.9M to 20.4MNotable
Why it matters: The company bought back stock, so each remaining holding owns slightly more of it. Worth checking it was not funded by borrowing.
Q2 FY2024 against Q2 FY2024, from the 10-Q filed Jul 31, 2026 — read it.
Improved: +15.1%
$202.3M to $232.9MSignificant
Why it matters: Profit swings far more than sales do, and one-off items — a legal settlement, a tax charge, an asset sale — move it without the underlying business changing.
Improved: +4.3 pts
59.0% to 63.3%Significant
Why it matters: What survives each sale before overheads. Falling gross margin usually means the company is discounting or its input costs rose — it is the earliest place pricing pressure shows.
Improved: +15.1%
$9.33 to $10.74Significant
Why it matters: Profit divided by the shares in issue at the period end, so it sits close to but not on the company's own reported figure. It can rise with no growth in profit when the company buys back stock — read it beside the share count.
Deteriorated: -16.9%
$61.8M to $51.4MSignificant
Why it matters: A falling cash pile is only a warning if the company is consuming it. Paying down debt, buying back stock and paying a dividend all reduce cash by choice.
Improved: +12.1%
$579.9M to $650.2MNotable
Why it matters: What is left of sales after the direct cost of producing them. It normally moves with revenue, so a move out of step with revenue is the part worth noticing.
Improved: +2.1 pts
20.6% to 22.7%Notable
Why it matters: What survives to the very end of each sale. Worth reading beside revenue: growing sales on a shrinking margin means the company is buying its growth.
8 other measures barely moved. Figures compare the two most recent annual filings — read the latest one. Moves are graded on fixed lines — 5%, 15% and 40% for amounts, and 1, 3 and 8 points for margins — as notable, significant or critical. Nothing here reads the management commentary, which is where a company explains its own numbers.
Filter by minute, hour, day or week — or compare against peers
Loading price history…
Discounted at 8%–10% a year, with growth settling to 2.5% after 10 years. Those rates are ordinary choices, not measurements: across that range the assumed growth works out between 13% and 18%. This describes what the price implies — it is not a forecast, and not a view on whether the price is right.
Opinions from 19 analysts covering this company, as of . Their views, not this site's.
Of 19 analysts publishing on this company, 4 say strong buy, 5 say buy, 9 say hold and 1 say sell. Analysts are paid to publish a view and are wrong often; the split above says how much they agree with each other, which is the part a single headline rating hides.
Published by Finnhub. Analyst coverage skews towards larger companies and towards optimism — sell ratings are rare across the whole market, so a company with none is ordinary rather than endorsed.
Measured on and published about a week later — this is a fortnightly snapshot, not a live position.
About 3.5% of this company's shares have been borrowed and sold by people expecting to buy them back cheaper. That is a bet the price falls. Those people can be wrong, and when a heavily shorted share rises they have to buy it back, which pushes it up further.
Collected by FINRA from broker-dealers twice a month. It counts positions, not intentions, and some of it is hedging rather than a directional bet against the company.
Nothing in this section is a figure this company reported about itself. These are expectations and positions — what the price implies, what analysts have published, what short sellers are betting, and what large funds held at the last count. WylthIQ reports them; it does not endorse them, does not forecast prices, and takes no view on whether any of them will turn out to be right.
The trailing P/E is 41.5x — a high multiple relative to the current trailing profit.
This company has not reported enough of the required figures to calculate this score.
| 7/9 |
| 4.0% |
| 21.6% |
| 39.30x |
| -158.08x |
| DHRDANAHER CORP /DE/ | 9.0/10 | 5/9 | 2.9% | 14.7% | 44.94x | 0.59x |
|---|
| AAGILENT TECHNOLOGIES, INC. | 9.0/10 | 6/9 | 6.7% | 18.8% | 37.77x | 0.89x |
|---|
| IQVIQVIA HOLDINGS INC. | 6.0/10 | 5/9 | 5.9% | 8.3% | 34.71x | 3.59x |
|---|
| WATWATERS CORP /DE/ | 9.0/10 | 6/9 | 7.0% | 20.3% | 42.22x | 0.98x |
|---|
| RVTYREVVITY, INC. | 6.0/10 | 6/8 | 3.7% | 8.4% | 73.25x | 0.68x |
|---|
| Median of peers | 9.0/10 | — | 5.9% | 14.7% | 42.22x | 0.89x |
|---|
Peers come from the company's industry classification. A difference describes the companies; it does not rank them.
Sold on the open market — 942 shares at $1.4K ($1.3M)
Holds 4,480 shares after this filing.
Exercised stock options — 417 shares at $397.95 ($165.9K)
Holds 709 shares after this filing.
Sold on the open market — 417 shares at $1.4K ($600.7K)
Holds 292 shares after this filing.
Exercised stock options — 2,240 shares at $595.31 ($1.3M)
Holds 7,819 shares after this filing.
Sold on the open market — 2,240 shares at $1.4K ($3.2M)
Holds 5,579 shares after this filing.
Exercised stock options — 240 shares at $720.81 ($173.0K)
Holds 499 shares after this filing.
Sold on the open market — 240 shares at $1.4K ($342.5K)
Holds 259 shares after this filing.
Exercised stock options — 415 shares at $397.95 ($165.1K)
Holds 707 shares after this filing.
Sold on the open market — 415 shares at $1.4K ($599.5K)
Holds 292 shares after this filing.
Notice filed ahead of a planned sale — the sale itself has not necessarily happened yet.
Filed notice to sell 417 shares ($600.7K) on or after .
Shares originally obtained via Stock Option exercise.
Filed notice to sell 415 shares ($599.5K) on or after .
Shares originally obtained via Stock Option exercise.
Filed notice to sell 832 shares ($1.2M) on or after .
Shares originally obtained via Stock Option Exercise.
Estimated from how often this has happened before, not a confirmed date.
Not investment advice, and not a signal to act on by itself — a filing says what happened, not why, and insiders trade for ordinary reasons having nothing to do with where they think the company is headed.
Published results
Had a director or senior officer leave or join
Read the filingHeld a shareholder vote
Read the filingQuarterly report for Q1 FY2026
Revenue +7.2% · Free cash flow -30.9% · Gross profit +5.7% — against Q1 FY2024
Read the filingPublished results
Read the filingProxy statement for a shareholder meeting
Read the filingAnnual report for FY2025
Long-term debt +14.0% · Cash +12.7% · Shares in issue -2.8% — against FY2024
Read the filingPublished results
Read the filingHad a director or senior officer leave or join · Made a Regulation FD disclosure
Read the filingQuarterly report for Q3 FY2025
Revenue +7.9% · Profit margin −1.0 pts · Gross profit +6.5% — against Q3 FY2024
Read the filingPublished results
Read the filingHad a director or senior officer leave or join
Read the filingHad a director or senior officer leave or join · Made a Regulation FD disclosure
Read the filingQuarterly report for Q2 FY2024
Profit margin −2.9 pts · Long-term debt +21.6% · Profit -8.8% — against Q2 FY2024
Read the filingPublished results
Read the filingHad a director or senior officer leave or join
Read the filingHeld a shareholder vote
Read the filingQuarterly report for Q1 FY2024
Profit -7.8% · Earnings per share -7.8% · Cash -8.4% — against Q1 FY2024
Read the filingThe first 40 of 42. The rest are in the exhibit.
Source: Exhibit 21 of the 10-K filed 2026-02-06. These are legal entities, not brands or acquisitions — a company that bought a business may hold it inside an entity named here, or inside one small enough that the rule does not require naming it at all.
Coverage from the last 30 days
Will Mettler-Toledo (MTD) Beat Estimates Again in Its Next Earnings Report?
Yahoo ·
1 Safe-and-Steady Stock to Target This Week and 2 Facing Challenges
Yahoo ·
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga ·
Morgan Stanley Maintains Equal-Weight on Mettler-Toledo Intl, Raises Price Target to $1575
Benzinga ·
Mettler-Toledo International Inc. to Host Investor Meeting
Yahoo ·
Mettler-Toledo (MTD) Upgraded to Buy: What Does It Mean for the Stock?
Yahoo ·
Take the Zacks Approach to Beat the Markets: HF Sinclair, Accenture & FirstCash in Focus
Yahoo ·
Mettler-Toledo International Inc. to Host Third Quarter 2026 Earnings Conference Call
Yahoo ·
Mettler-Toledo (MTD): AI-Driven Pharma R&D Productivity Catalyzes Growth
Yahoo ·
Shares Of Mettler-Toledo International Are Still Too Pricey For My Liking
SeekingAlpha ·
Mar Vista U.S. Quality Premier Portfolio Q3 2026 Activity
SeekingAlpha ·
Barclays Maintains Overweight on Mettler-Toledo Intl, Raises Price Target to $1700
Benzinga ·
Primary sources and further research